title: Incomplete Brown-Séquard syndrome after methamphetamine injection into the neck.
authors.affiliation: Department of Neurology, University of California, San Francisco, USA.
authors.forename: Wender
authors.initials: W
authors.lastname: Hwang
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Ralph
authors.forename: Elysa
authors.initials: E
authors.lastname: Marco
authors.forename: J Claude
authors.initials: JC
authors.lastname: Hemphill
mesh_terms: D000085:Acetates / Q000627:therapeutic use; D000328:Adult; D000588:Amines; D018437:Brown-Sequard Syndrome / Q000209:etiology* / Q000503:physiopathology; D002422:Causalgia / Q000188:drug therapy / Q000209:etiology; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D006801:Humans; D007238:Infarction / Q000139:chemically induced* / Q000503:physiopathology; D007267:Injections; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage / Q000009:adverse effects*; D009020:Morphine / Q000627:therapeutic use; D009333:Neck; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000009:adverse effects; D013116:Spinal Cord / Q000098:blood supply*; D013119:Spinal Cord Injuries / Q000209:etiology* / Q000503:physiopathology; D020760:Spinal Cord Ischemia / Q000139:chemically induced / Q000503:physiopathology; D015819:Substance Abuse, Intravenous / Q000150:complications*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D012597:Sclerosing Solutions; D014662:Vasoconstrictor Agents; D008694:Methamphetamine; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D009020:Morphine; D008140:Lorazepam